Gandhi, Pranav K <br/><br/>
Cost-effectiveness analysis of allopurinol versus febuxostat in chronic gout patients: a U.S. payer perspective.  [electronic resource] 

 -  Journal of managed care & specialty pharmacy  Feb 2015 
 - 165-75 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>2376-1032 
<br/><br/><label>Standard No.: </label>10.18553/jmcp.2015.21.2.165  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Allopurinol--therapeutic use<br/>Chronic Disease<br/>Cost-Benefit Analysis<br/>Febuxostat<br/>Gout--blood<br/>Gout Suppressants--therapeutic use<br/>Humans<br/>Markov Chains<br/>Thiazoles--therapeutic use<br/>Uric Acid--blood